News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
JFL Capital Management, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/24/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc. |
| 07/24/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc. |
| 05/31/2019 |
SC 13G
| JFL Capital Management, LLC reports a 6% stake in Novelion Therapeutics Inc. |
| 04/17/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 9.3% stake in Merrimack Pharmaceuticals, Inc. |
| 03/14/2019 |
SC 13D/A
| JFL Capital Management, LLC reports a 8.7% stake in Merrimack Pharmaceuticals, Inc. |
| 02/11/2019 |
SC 13G/A
| JFL Capital Management, LLC reports a 7% stake in Catalyst Biosciences, Inc. |
| 01/25/2019 |
SC 13G
| JFL Capital Management, LLC reports a 8.2% stake in Sunesis Pharmaceuticals, Inc. |
| 12/19/2018 |
SC 13D/A
| JFL Capital Management, LLC reports a 8.5% stake in Merrimack Pharmaceuticals, Inc. |
| 11/02/2018 |
SC 13D
| JFL Capital Management, LLC reports a 7.1% stake in Merrimack Pharmaceuticals, Inc. |
| 08/02/2018 |
SC 13G
| JFL Capital Management, LLC reports a 5.4% stake in Catalyst Biosciences, Inc. |
| 10/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|